Home Food Regulatory News EFSA Safety Evaluation of Long‐Chain Glycolipids from Dacryopinax spathularia EFSA Safety Evaluation of Long‐Chain Glycolipids from Dacryopinax spathularia Jun 16, 2021 | Additives | Regulatory News | News Posted By: Ognjen Djunisijevic Share: On June 14, 2021, the European Food Safety Authority scientific opinions on the Food Additives and Flavourings (FAF) provided the “Safety of long‐chain glycolipids from Dacryopinax spathularia” (also called AM‐1) as a food additive preservative in beverages. The scope of the assessment on AM-1 is highlighted as follows: A purified mixture of long‐chain glycolipid congeners obtained by fermentation of the edible non‐genetically modified fungus Dacryopinax spathularia. Low oral bioavailability and toxicology data do not demonstrate any adverse effects of the proposed food additive. Based on the data study, an ADI of 10 mg/kg bw per day based on a range of no-observed-adverse-effect between 1,000 and 1,423 mg/kg bw per day (the highest doses tested) tested on rats. At the proposed maximum use levels, the exposure estimates ranged at the mean from 0.01 to 1.07 mg/kg bw per day and at the p95 from 0 to 3.1 mg/kg mg/kg bw per day. The highest estimate of exposure of 3.1 mg/kg bw per day (in toddlers) is within the established ADI of 10 mg/kg bw per day EFSA concluded that the exposure to long‐chain glycolipids from Dacryopinax spathularia does not raise a safety concern. To view the complete safety assessment report, check out the Food News Monitoring System.